[HTML][HTML] Relaxin-2 as a potential biomarker in cardiovascular diseases

A Aragón-Herrera, S Feijóo-Bandín… - Journal of personalized …, 2022 - mdpi.com
The pleiotropic hormone relaxin-2 plays a pivotal role in the physiology and pathology of the
cardiovascular system. Relaxin-2 exerts relevant regulatory functions in cardiovascular …

[HTML][HTML] Relaxin-2 in cardiometabolic diseases: mechanisms of action and future perspectives

S Feijóo-Bandín, A Aragón-Herrera… - Frontiers in …, 2017 - frontiersin.org
Despite the great effort of the medical community during the last decades, cardiovascular
diseases remain the leading cause of death worldwide, increasing their prevalence every …

'Relaxin'the stiffened heart and arteries: the therapeutic potential for relaxin in the treatment of cardiovascular disease

CS Samuel, XJ Du, RAD Bathgate… - Pharmacology & …, 2006 - Elsevier
Although originally characterised as a reproductive hormone, relaxin has emerged as a
multi-functional endocrine and paracrine factor that plays a number of important roles in …

Relaxin'the heart: a novel therapeutic modality

JMV Raleigh, S Toldo, A Das… - Journal of …, 2016 - journals.sagepub.com
The peptide hormone relaxin has traditionally been linked to the maternal adaptation of the
cardiovascular system during the first trimester of pregnancy. By promoting nitric oxide …

Relaxin as a cardiovascular hormone: physiology, pathophysiology and therapeutic promises

S Nistri, M Bigazzi, D Bani - Cardiovascular & Hematological …, 2007 - ingentaconnect.com
Relaxin is a hormone belonging to the so-called relaxin superfamily, which also includes
insulin-like peptides. Relaxin is best known for its effects on the female reproductive system …

Relaxin and the cardiovascular system: from basic science to clinical practice

RC Martins, M Pintalhão… - Current Molecular …, 2020 - ingentaconnect.com
The peptide hormone relaxin was originally linked to reproductive physiology, where it is
believed to mediate systemic and renal hemodynamic adjustments to pregnancy. Recently …

Recombinant human H2 relaxin (serelaxin) as a cardiovascular drug: aiming at the right target

D Bani - Drug Discovery Today, 2020 - Elsevier
Highlights•Serelaxin (human relaxin-2) had raised hope as a possible cardiovascular
drug.•The clinical trials with serelaxin in acute heart failure gave disappointing …

[HTML][HTML] Recent progress in the understanding of relaxin family peptides and their receptors

RJ Summers - British journal of pharmacology, 2017 - ncbi.nlm.nih.gov
The 7th International Conference in the series on 'Relaxin and related peptides' covered all
aspects of the basic biology of relaxin (human H2-relaxin), its potential clinical applications …

The actions of relaxin on the human cardiovascular system

M Sarwar, XJ Du, TB Dschietzig… - British Journal of …, 2017 - Wiley Online Library
The insulin‐like peptide relaxin, originally identified as a hormone of pregnancy, is now
known to exert a range of pleiotropic effects including vasodilatory, anti‐fibrotic, angiogenic …

Serelaxin in clinical development: past, present and future

E Unemori - British Journal of Pharmacology, 2017 - Wiley Online Library
The availability of highly purified recombinant human relaxin, serelaxin, has allowed clinical
trials to be conducted in several indications and the elucidation of its pharmacology in …